ANNEXON, INC. Shares Outstanding (Cover Page)
ANNEXON, INC. (ANNX) had Shares Outstanding (Cover Page) of 38.56 million shares as of 2022-05-02, per its 10-Q filed 2022-05-09.
Discontinued › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2022-05-09
- 2022-05-02: Entity Common Stock, Shares Outstanding 38.56M shares.
- 2022-02-25: Entity Common Stock, Shares Outstanding 38.56M shares.
- 2021-10-29: Entity Common Stock, Shares Outstanding 38.37M shares.
- 2021-08-10: Entity Common Stock, Shares Outstanding 38.33M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2022-05-02 | 38.56M shares 10-Q · filed 2022-05-09 |
| 2022-02-25 | 38.56M shares 10-K · filed 2022-03-01 |
| 2021-10-29 | 38.37M shares 10-Q · filed 2021-11-09 |
| 2021-08-10 | 38.33M shares 10-Q · filed 2021-08-16 |
| 2021-04-30 | 38.26M shares 10-Q · filed 2021-05-17 |
| 2021-03-15 | 38.16M shares 10-K · filed 2021-03-25 |
| 2020-10-31 | 38.16M shares 10-Q · filed 2020-11-16 |
| 2020-08-31 | 38.15M shares 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |